2023
DOI: 10.1101/2023.08.29.555234
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

A mutant fitness compendium in Bifidobacteria reveals molecular determinants of colonization and host-microbe interactions

Anthony L. Shiver,
Jiawei Sun,
Rebecca Culver
et al.

Abstract: Bifidobacteria commonly represent a dominant constituent of human gut microbiomes during infancy, influencing nutrition, immune development, and resistance to infection. Despite interest as a probiotic therapy, predicting the nutritional requirements and health-promoting effects of Bifidobacteria is challenging due to major knowledge gaps. To overcome these deficiencies, we used large-scale genetics to create a compendium of mutant fitness inBifidobacterium breve(Bb). We generated a high density, randomly barc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

2
5

Authors

Journals

citations
Cited by 11 publications
(4 citation statements)
references
References 99 publications
(176 reference statements)
0
4
0
Order By: Relevance
“…In order to validate the predicted starch-degrading activity of the product of amy1 , as its activity was not obvious from the previous enzymatic assays, the gene was cloned under the control of a constitutive promoter (see Materials and Methods), resulting in plasmid pBC1.2: amy1 . Plasmid pBC1.2: amy1 was then introduced in B. breve UCC2003:ΔApuBP8, which is a derivative of UCC2003 in which the apuB gene had been interrupted by transposon mutagenesis, thus making this strain unable to grow in starch or starch-like glycans ( O’Connell Motherway et al, 2008 ; Shiver et al, 2021 , 2023 ).…”
Section: Resultsmentioning
confidence: 99%
“…In order to validate the predicted starch-degrading activity of the product of amy1 , as its activity was not obvious from the previous enzymatic assays, the gene was cloned under the control of a constitutive promoter (see Materials and Methods), resulting in plasmid pBC1.2: amy1 . Plasmid pBC1.2: amy1 was then introduced in B. breve UCC2003:ΔApuBP8, which is a derivative of UCC2003 in which the apuB gene had been interrupted by transposon mutagenesis, thus making this strain unable to grow in starch or starch-like glycans ( O’Connell Motherway et al, 2008 ; Shiver et al, 2021 , 2023 ).…”
Section: Resultsmentioning
confidence: 99%
“…As proof-of-principle we focused on published chemical genetics data from E. coli 31 , because of the large number of antibiotics screened at different concentrations and the extensive benchmarking. In the future, similar analyses can be expanded to other available datasets in the same or other species 34,47,[53][54][55][56] . Such datasets will inevitably increase with time, as genome-wide mutant libraries are becoming available in tens of species and even more strains 57,58 , whether those are arrayed or pooled 29,59 , and constructed by targeted deletions [60][61][62] , transposon insertions 59,63 , or CRISPRi knockdowns 53,64 .…”
Section: Discussionmentioning
confidence: 99%
“…For example, the end products of bifidobacterial carbohydrate metabolism, lactate and acetate, can inhibit pathogen colonization [19][20][21] and serve as a basis for cross-feeding with various community members 22,23 . Additionally, multiple Bifidobacterium species produce aromatic lactic acids and other metabolites that modulate the immune system [24][25][26][27] . Given these beneficial properties, some bifidobacterial strains are commonly administered as probiotics [28][29][30][31][32] .…”
Section: Introductionmentioning
confidence: 99%